New breast marker aims to make surgery smoother for patients and surgeons

NCT ID NCT06294574

Recruiting now Disease control Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares a new breast biopsy marker, HydroMARK Plus, with the standard marker to see if it is easier for surgeons to find and remove during breast cancer surgery. About 150 patients scheduled for surgery with SCOUT localization will take part. The main goal is to measure how often the new marker is successfully retrieved and how satisfied surgeons are with it.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HydroMARK Plus breast biopsy site marker
What this could lead to: If successful, this could make breast cancer surgeries more efficient by helping surgeons find and remove biopsy markers more reliably.
What could go wrong: This is a small, early-stage study focused on device retrieval, not on curing or treating cancer. The new marker may not be easier to retrieve, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST NEOPLASM

Contacts and locations

Locations

The Kirklin Clinic
RECRUITING

Birmingham, Alabama, 35249, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.